Tuberculosis :: Developing a more effective tuberculosis vaccine
The microorganism that causes tuberculosis, M. Tuberculosis, infects more than a one third of the world’s population.
Medicine
Antidepressant :: Success or failure of antidepressant citalopram predicted by gene variation
A variation in a gene called GRIK4 appears to make people with depression more likely to respond to the medication citalopram (Celexa) than are people without the variation, a study by the National Institute of Mental Health (NIMH), part of the National Institutes of Health, has found.
Vaccine :: CDC urges parents to protect preteens with three recommended vaccines
As children approach their teen years, parents often worry about how to protect them from new risks and potential dangers. Experts at the Centers for Disease Control and Prevention (CDC) launched a campaign to educate parents about one of the things they can do to protect their children at 11 and 12 years of age and for years to come: make sure they are vaccinated against serious, sometimes life-threatening diseases such as meningitis, tetanus, diphtheria, whooping cough, and cervical cancer.
Avandia :: Keep GSK diabetes drug Avandia available to US patients
The FDA Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee voted to keep the Glaxo’s diabetes medicine Avandia available to patients in the US. The FDA will review the panel’s recommendation before making a decision.
Blood Transfusion :: National blood donor pool significantly smaller than previously thought
According to a new study in TRANSFUSION, the number of individuals in the U.S. who are eligible to donate blood may be smaller than previously believed ? approximately 60 million fewer people.
Cancer :: Gold nanoparticles may pan out as tool for cancer diagnosis
When it comes to searching out cancer cells, gold may turn out to be a precious metal. Purdue University researchers have created gold nanoparticles capable of identifying marker proteins making the tiny particles a potential tool to better diagnose and treat breast cancer.
Contraceptive :: Today Sponge Contraceptive – New Look for Women of Today
Synova Healthcare Group, Inc. announced that the Today(r) Sponge, the first and only female contraceptive to combine a spermicide with a barrier contraceptive, is unveiling its exciting new look this summer.
Schizophrenia :: Researcher simulates schizophrenia in healthy people
To better understand schizophrenia, a University of Missouri-Columbia psychology researcher simulated one of its more common symptoms – the inability to speak clearly or respond to questions in a precise manner – in people who don’t have the illness.
Pregnancy :: Lower Cesarean rates associated with preventive labor induction
At a time when national rates of cesarean delivery have climbed above 30%, a four-year study of patients receiving an alternative method of obstetric care experienced a significantly lower rate of cesarean births, according to a study published in the current issue of the Annals of Family Medicine.
Healthcare :: Africa – International volunteer impact small, but significant
International health volunteers make a small yet significant contribution in sub-Saharan Africa, according to research published in the online open access journal Human Resources for Health. Medical volunteer numbers remain low, and resources are shifting to local capacity building initiatives.